Similar articles

• Harmful effects of NSAIDs among patients with hypertension and coronary artery disease.

  Bavry AA, Khaliq A, Gong Y, Handberg EM, Cooper-Dehoff RM, Pepine CJ. Bavry AA, et al. Am J Med. 2011 Jul;124(7):614-20. doi: 10.1016/j.amjmed.2011.02.025. Epub 2011 May 18. Am J Med. 2011. PMID: 21596367 Free PMC article.
• Updates on NSAIDs in patients with and without coronary artery disease: pitfalls, interactions and cardiovascular outcomes.

  Gargiulo G, Capodanno D, Longo G, Capranzano P, Tamburino C. Gargiulo G, et al. Expert Rev Cardiovasc Ther. 2014 Oct;12(10):1185-203. doi: 10.1586/14779072.2014.964687. Epub 2014 Sep 15. Expert Rev Cardiovasc Ther. 2014. PMID: 25220474 Review.
• Hypertension control and cardiovascular outcomes among patients with diabetes and coronary artery disease.

  van Hateren KJ, Bilo HJ. van Hateren KJ, et al. JAMA. 2010 Oct 20;304(15):1672; author reply 1672-3. doi: 10.1001/jama.2010.1464. JAMA. 2010. PMID: 20959575 No abstract available.
• Validation studies of the health improvement network (THIN) database for pharmacoepidemiology research.

  Lewis JD, Schinnar R, Bilker WB, Wang X, Strom BL. Lewis JD, et al. Pharmacoepidemiol Drug Saf. 2007 Apr;16(4):393-401. doi: 10.1002/pds.1335. Pharmacoepidemiol Drug Saf. 2007. PMID: 17066486
• Medical prevention of stroke, 2003.

  Kirshner HS. Kirshner HS. South Med J. 2003 Apr;96(4):354-8. doi: 10.1097/01.SMJ.0000063469.77850.08. South Med J. 2003. PMID: 12916553 Review.